• Ave. 31 No. 15802 between 158 y 190, Cubanacán, Playa, Havana. C.P. 10600, P.O. Box 6162
  • webmaster@cigb.edu.cu
  • (53) 7-2504101; (53) 7-2716022
We design and produce the first vaccine against COVID-19 in Cuba and Latin America About us Distinctive company of Cuban biotechnology About us We research, produce and commercialize biotechnological and pharmaceutical products About us We work with social responsibility and in harmony with the environment About us We offer innovative biotechnological applications for the biomedical, veterinary, agricultural, aquaculture and industrial sectors About us Agricultural biotechnology with its own technology and varieties of Cuban plants ¿Quiénes somos?

Message from the Director General

“We have been able to motivate young people to become what we have become. We had the opportunity to work with a very committed generation, and we have a duty to follow that example.”

Our studies focus on

Research areas

that generate a positive impact on human, animal and plant health, as well as industrial productions, in harmony with the environment, to contribute to the socioeconomic development of Cuba

Our directives

HeberFERON®

Pharmaceutical combination in synergistic ratio of recombinant human interferon alpha 2b and recombinant human...

Results

From Phase III clinical study of Abdala

After using 1st dose of HeberFERON®
77%
In patients with viral persistence
75%
At the end of the treatment
55%
Upcoming events

Where you can know our results

We work for one health

We offer + 25 products

Our products are preventive, therapeutic or diagnostic. We design products first and only of its kind for diseases that have no other effective therapeutic solutions.

What do we work on?

Main processes